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Summary 
A new procedure for rapid isolation of dendritic cells (DC) was devised, involving collagenase 
digestion of tissues, dissociation of lymphoid-DC complexes, selection of light-density cells, then 
depletion of lymphocytes and other non-DC by treatment with a mixture of lineage-specific 
monoclonal antibodies (mAbs) and removal with antiimmunoglobulin-coupled magnetic beads. 
This enriched population (~80% DC) was further purified when required by fluorescence-activated 
cell sorting for cells expressing high levels of class II major histocompatibility complex (MHC). 
The isolated DC were characterized by immunofluorescent staining using a panel of 30 mAbs. 
Thymic DC were surface positive for a number of markers characteristic of T cells, but they 
were distinct from T-lineage cells in expressing high levels of class II MHC, in lacking expression 
of the T cell receptor (TCK)-CD3 complex, and having TCK/3 and 3" genes in germline state. 
Splenic DC shared many markers with thymic DC, but were negative for most T ceU markers, 
with the exception of CD8. A substantial proportion of DC from both thymus and spleen expressed 
CD8 at high levels, comparable with that on T cells. This appeared to be authentic CD8, and 
was produced by the DC themselves, since they contained CD8ce mRNA. Thymic DC presented 
both the CD8 c~ and/3 chains on the cell surface (Ly-2+3+), although the ce chain was in excess; 
the splenic DC expressed only the CD8 ol chain (Ly-2  +  3-). h  is suggested that the expression 
of CD8 could endow certain antigen-presenting DC with a veto function. 
D 
endritic cells (DC), 1 first described by Steinman et al. 
(1, 2), are a minor population of irregularly shaped cells 
in lymphoid organs, distinguishable from both lymphocytes 
and macrophages.  DC constitutively express high levels of 
both class I and class II MHC antigens (1, 2). They are highly 
efficient at presentation of antigen and stimulation of T lym- 
phocytes (1-7). Those within the thymus are believed to effect 
deletion of developing T cells with self-reacting potential (8, 
9). The surface  antigenic pattern of thymic DC has been shown 
to differ somewhat from that of splenic DC (10-12), but it 
is not dear whether this implies the cells have a different origin, 
or a different  function, or whether they simply represent 
different development states of the same functional lineage. 
1 Abbreviations used in thispaper: BSS, balanced salt solution; DC, dendritic 
cell; HSA, heat-stable antigen. 
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There is evidence that it is the developmental  state of the 
T  cell that determines whether the T  cell-DC interaction 
leads to T cell proliferation  or to T cell death (13). As part 
of a study of the interaction between developing T cells in 
the thymus and thymic stromal elements (14), we have iso- 
lated thymic DC and compared them with those isolated from 
the spleen. 
The usual procedure for isolating DC involves enrichment 
in a low buoyant density fraction by centrifugation, followed 
by selection as cells that show an initial adherence but then 
release from the vessel surface when cultured overnight (10). 
We have used such a procedure to isolate DC from mouse 
thymus (15). However, we were concerned that the associa- 
tion of many thymic DC with thymocytes to form dense 
and nonadherent rosettes (14, 16) would prevent their isola- 
tion in this way, and that overnight culture stage might change 
their phenotype (7). In addition, we noted a disturbing inci- 
dence of thymocytes intimately bound to the enriched DC, 
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lems led us to question  the apparent  expression of certain 
T  cell markers by thymic DC preparations. Accordingly, we 
developed a procedure that incorporated a step to dissociate 
DC-lymphocyte complexes, and which allowed a rapid en- 
richment of DC by immunomagnetic bead depletion, without 
the culture  step.  The resulting  DC  preparations  were free 
of lymphocytes but still displayed several markers normally 
found on T  cells.  We have examined this  critically and in 
particular verified the expression of surprisingly high levels 
of CD8 by a subpopulation of both thymic and splenic DC. 
Materials and Methods 
Animals.  The mice were specific pathogen-free 5-7-wk-old fe- 
males bred at The Walter and Eliza Hall Institute animal facility. 
Unless otherwise specified, the strain was C57BL/6J Wehi (Thy- 
1.2,  Ly-2.2).  In some experiments, the C57BL Ka (Thy-l.1, Ly- 
2.2) or the CBA Call Wehi (Thy-l.2, Ly-2.1) strains  were used. 
mAbs.  Most hybridomas were grown and the mAbs purified 
and conjugated in this laboratory. The mAbs used, the hybridoma 
clone numbers, and their antigenic specificities are listed in Table 1. 
Immunofluorescent Staining and Flow Cytometry.  The staining, 
flow cytometry analysis, and sorting procedures were similar  to 
those described previously (42). All DC preparations were prein- 
cubated  with  a  rat  Ig-mouse  Ig  mix  to  minimize nonspecific 
binding.  In  the  routine,  procedure  cells  were  stained  with 
fluorescein-conjugated mAb against MHC class II (M5/114 for 
C57BL/6,  14.4.4S  for CBA), with PE-conjugated mAb against 
CD8o~ (53-6.7), and with a third biotin-conjugated mAb from 
Table 1, using as the second-stage  reagent a Texas red-streptavidin 
conjugate (Caltag Laboratories,  South San Francisco,  CA).  The 
single-color  stains  used  the  biotin-conjugated  mAb  and  Texas 
red-streptavidin second stage. Propidium iodide (1 #g/ml) was in- 
cluded in the final cell wash. Multiparameter analysis and sorting 
utilized a FACStar Plus  |  while single parameter analysis utilized 
a FACScan  |  (Becton Dickinson & Co., Mountain View, CA). For- 
ward light scatter and propidium iodide staining gates  were set 
to exclude dead cells. 
Cell Suspension Media.  Cells  were suspended in a mouse os- 
molarity, pH 7.2, Hepes-buffered  balanced salt solution (BSS) con- 
raining 5% FCS (BSS-FCS). For digestion procedures, the medium 
was R.PMI  1640, modified to mouse osmolarity, with additional 
pH 7.2 Hepes buffering, containing 2% FCS (RPMI 1640-FCS). 
To avoid reassociation  of DC with T cells, the medium used was 
EDTA-BSS-FCS, a balanced salt solution isoosmotic with mouse 
serum but lacking Ca  2+ and Mg  2+  and including 5/zM EDTA; 
to this was added 5% FCS-EDTA, FCS that had Ca  7§ and Mg  2+ 
chelated by the addition of 1 ml 0.099 M EDTA per 10 ml serum. 
Mechanically Dissociated Lymphoid Cell Suspensions.  Suspensions 
containing predominantly lymphoid cells were prepared from spleen 
or thymus by teasing into cold BSS-FCS, settling to remove large 
debris, then washing by spinning through a layer of FCS. The cells 
were then suspended in cold BSS-FCS. 
DC Isolation.  Thymuses (10-30) or spleens (5-20) were teased 
apart or chopped into small fragments with scissors, then agitated 
in 10 ml BSS-FCS by rapidly pipetting up and down a wide-bore 
Pasteur pipette. After a brief settling to collect large stromal frag- 
ments, the supernatant was collected and lightly centrifuged (cen- 
trifuge accelerated  up to 1,000 rpm, then immediately switched 
off) to collect small fragments and lympho-stromal complexes. The 
supernatant containing free cells was removed. This process was 
repeated three to four times, using the washings of the large stromal 
fragments to wash the small-fragment pellet, which was again col- 
lected by light centrifugation. The washed large and small stromal 
fragments were then pooled. The pooled stromal fragments were 
then digested with collagenase (1 mg/ml; Boehringer-Mannheim, 
Mannheim, West Germany) and DNAse (0.02  mg/ml; grade II 
bovine pancreatic DNAse I;  Boehringer-Mannheim), in  7.5  ml 
RPMI 1640-FCS for 25 min at 22~  with continuous agitation. 
This procedure follows that previously used to isolate thymic ro- 
settes (14, 43). The rosettes were then dissociated  by adding 0.6 
ml of 0.099 M EDTA, pH 7.2, and continuing the incubation for 
5 min. To avoid rosette reformation, all separation  steps from this 
point to the last depletion were carried out in EDTA-BSS-FCS, 
and any serum used was  FCS-EDTA. 
Cold FCS-EDTA was layered underneath the digest, and the cells 
were recovered  by centrifugation at 500 g for 7 min. The cells were 
resuspended in cold isoosmotic Metrizamide solution (Nyegaard 
Diagnostics, Oslo, Norway), pH 7.2, density 1.075 g/cm  3, con- 
taining 5 mM EDTA, and a low-density cell fraction selected by 
centrifugation for 10 min at 1,700 g, as described elsewhere (44). 
The recovered low-density cells were treated with a cocktail con- 
taining titrated levels of the following mAbs to coat non-DC: anti- 
CD3,  KT3-1.1; anti-CD4,  GK1.5; anti-Thy-l.2, 30-H12, or for 
Thy-l.1 mice, 19F12; anti-Ib2R~, PC61; anti-Gr-1, RB68C5; anti- 
Mac-lc~, M1/70.15; antimacrophage F4/80 antigen, F4/80; anti- 
B220, RA36B2; antierythroid, TER119; anti-FcR II, 2.4G2. Fur- 
ther details are in Table 1. Most mAbs were used at near-saturation 
levels, as for optimal cell staining.  However, the mAbs specific for 
Thy-1, Mac-l, and FcKII, which are expressed at low levels on DC, 
were titrated in trial experiments and used at reduced levels so that 
only cells expressing high levels of these antigens were depleted. 
Incubation was for 25 min at 4~  after which the cells were washed 
by layering over and spinning through FCS-EDTA.  The cells were 
then depleted twice with anti-Ig-coated magnetic beads  (using a 
1:1 mixture of anti-rat Ig and anti-mouse Ig coupled Dynabeads, 
Dynal, Oslo) first at 7:1 then at 3:1 bead-to-cell ratios. The bead 
and cell mix was resuspended as a slurry in EDTA-BSS-FCS and 
incubated for 20 min at 4~  with continuous slow rotation. The 
mix was then diluted with 5 ml EDTA-BSS-FCS, and the beads 
were removed magnetically, using two removal cycles. In many ex- 
periments this depleted preparation was used directly, with gating 
during analysis for class II MHC bright (or CD8 bright) cells to 
selectively analyze DC. In other experiments the preparation was 
stained and sorted for class II MHC bright cells, to provide a pure 
DC preparation. 
In some cases mechanically released free DC were also isolated 
from the free lymphoid cell suspension,  by beginning isolation at 
the density separation step (see above). 
Phase Contrast Microscoi~.  Purified DC were suspended at 2  x 
104 cells/ml and incubated for 12-24 h at 37~  as 15-/zl hanging- 
drop cultures in the wells of inverted Terasaki trays. The medium 
was pH 7.2 Hepes-buffered RPMI 1640 containing 10 -4 M 2-ME, 
10% FCS, and 10% ofa supematant of Con A-stimulated rat spleen 
cell cultures. The gas phase was 10% CO2 in air, and water satu- 
rated. The trays were then turned over and incubated for a further 
30 min to allow the DC to settle onto the flat bottom of the wells. 
The cells were examined at 400-fold magnification using a Nikon 
Diaphot inverted phase  microscope. 
Gel Hybridization Analysis.for TCR Gene DNA Rearrangement. 
DNA was prepared from 5  x  10  s cells as described previously 
(45).  For TCR B gene rearrangement, DNA was digested with 
HindlII and hybridized with a C/~ probe. For TCP, 3' gene rear- 
rangement, DNA was digested with EcoRI and hybridized with 
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two germline bands at 9.4 and 3.0 kb for C~ genes, and three germ- 
line bands at  13.4, 10.5, and 7.5 kb for C7 genes. 
RNAse Protection Assay  for CD8 mRNA.  An EcoRI/PstI frag- 
ment of a Ly-2.2 clone (46) was cloned into the pGEM3 vector 
polylinker, and used as a template for the transcription of a 284-bp 
[32p]UTP-labeled riboprobe (Promega Biotec, Madison, WI). The 
probe was eluted from a polyacrylamide gel and hybridized over- 
night with sample RNA at 42~  in 80% formamide, 0.4 M NaC1, 
40 mM piperazine-N,N'-bis(2-ethanesulfonic acid) buffer, pH 6.4, 
10 mM EDTA. Single-stranded RNA was digested with RNAse 
A and RNAse T1, then samples were phenol extracted, precipi- 
tated with 10/~g tRNA, and subjected to electrophoresis on a 7% 
polyacrylamide gel. Bands were detected by autoradiography or on 
a phosphoimager  (Molecular Dynamics, Sunnyvale, CA). 
Results 
Development of the Isolation Procedure.  The procedure was 
developed for thymic DC, but was applicable to splenic DC. 
The tissue disruption conditions had been established for op- 
timum yield of DC-thymocyte rosettes (14, 43). Teasing, agi- 
tation, and washing of the tissue removed 75% of lymphoid 
cells, thereby enriching the DC in the stromal residue. How- 
ever, this procedure also  released some DC,  in the case of 
spleen "~30% of all recoverable DC; the implications of this 
are considered later.  Collagenase digestion of the residual 
stroma at room temperature released both free DC and DC- 
lymphocyte rosettes (14,  16).  The digest was treated with 
EDTA to completely disrupt rosettes (14), and the presence 
Table  1.  The mAbs  Used  for DC Purification and Characterization 
Alternative  designation 
Antigen  or specificity  Hybridoma clone  Reference or source 
CD8 cz chain  Pan Ly-2  53-6.7  17 
Pan Ly-2  YTS169.4  Caltag Laboratories 
Ly-2.1  49-11.1  18 
Ly-2.2  D9  19 
CD8 B chain  Pan Ly 3  53-5.8  17; Pharmingen  (San Diego, CA) 
CD4  GK1.5  20 
Class I MHC  H-2K  k  11-4.1  21 
H-2K  d'b'q'r's D d  34.1.2S  22 
Class II MHC  I_A  k  ....  ER-TR2  23 
I-A  b'd'q I-E  d'k  M5/114  24 
I-E/C  Ld'p'r  14-4.4S  25 
CD2  RM2-2  26 
CD45  Ly 5  AL14A2  27 
CD45R  B220  RA36B2  28 
CD44  Pgp-1  1M7.81  29 
CD25  IL-2Kc~  PC61  30 
CD3  KT3-1.1  31 
TCR 3,/8  GL3-1A  32 
Thy 1  Thy-l.1  19-F12  33 
Thy-l.2  30-H12  17 
HSA  Jlld  M1/69  34 
FcR II  2.4G2  35 
LFA-1  I21/7.7  36 
Mac-1  Mac-la  M1/70.15  34 
F4/80  Macrophage  F4/80  37 
Gr-1  Granulocyte  RB68C5  38 
TER-119  Erythroid  TER-119  Kina et al.,  manuscript  in preparation 
33D 1  Dendritic  33D 1  39 
NLDC145  Dendritic  NLDC145  40; BMA (Augst,  Switzerland) 
MTS 35  MTS 35  41;  R. Boyd (Monash University, 
Melbourne,  Australia) 
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reforming complexes with lymphocytes. The DC were then 
enriched on the basis of their low buoyant density by cen- 
trifugation in metrizamide medium (44), a modification of 
established procedures (1). A mean of 92% of lymphocytes 
sedimented at the density used, whereas 80% of  DC floated. 
The DC were still a minority of the light-density frac- 
tion.  Lymphocytes,  macrophages,  and  most  other  con- 
taminating cell types were removed by coating the ceils with 
a mixture of  mAbs, each recognizing specific  lineage markers, 
mixing the coated calls with anti-Ig-coupled magnetic beads, 
then removing the unwanted cells with a magnet. The ex- 
pression of  low levels of some T cell and macrophage markers 
by thymic DC (11) was an initial concern. However, it be- 
came apparent that the magnetic bead depletion  technique 
removed only cells expressing high levels of surface antigens, 
and with adjustment of mAb concentration, an appropriate 
cut-offcould be set. Accordingly,  the mAbs recognizing Thy-1, 
Mac-l, and FcR were used at moderate, rather than saturating, 
levels. To check the depletion specificity of the mAbs used, 
they were omitted one at a time from the depletion cocktail, 
and the changes in both total cell recovery and cell surface 
phenotype were assessed. Omission of any one mAb caused 
an increase in contaminants,  extensive in some cases (e.g., 
anti-Thy-1), minor but still detectable in others (e.g., anti- 
Ib2R). However, in no case was DC recovery significantly 
improved by omission of one mAb. In contrast to the mAbs 
finally used in the depletion  cocktail,  the addition of anti- 
CD8 in trial  experiments  resulted in a major drop in the 
recovery of  class II MHC bright DC, and accordingly, it was 
excluded from the cocktail. 
The twice-depleted preparations contained 75-95% DC, 
defined as the class II MHC bright calls. A low level of 
lymphocyte, macrophage,  and epithelial cell contaminants 
('~10%) was detected on smeared and stained samples. Recov- 
eries of DC from the collagenase-digested washed stromal 
residue ranged from 1 to 5  x  10  s per thymus, and 5 to 9 
x  10  s per spleen.  This preparation  was used directly for 
flow cytometric  analysis, gating for MHC class II bright cells 
to sdectivdy analyze  the DC component. Higher purity prepa- 
rations  for molecular or  functional analysis were readily 
obtained by positive sorting for class II MHC bright cells, 
which reduced the level of class II MHC dull calls, and the 
level of evident lymphocyte  and macrophage contamination, 
to <1%. 
Morphological  Appearance  of  DC Preparations.  If examined 
immediately under phase-contrast microscopy, only m20% 
of the cells in the final preparation showed typical DC mor- 
phology,  the majority appearing as medium- to large-sized 
round calls with only a few fine protrusions.  However, the 
typical DC morphology of convoluted shape, with cell ex- 
tensions in the form of dendrites or veils, began to appear 
after short periods of  culture. Survival was best and dendritic 
morphology most evident in low-density hanging-drop cul- 
tures, in a medium containing the mixture of  cytokines  released 
by mitogen-activated  lymphocytes. After overnight culture 
of the depleted, but not sorted, DC preparations, 60-80% 
of the cells in the thymic preparations, and 30-60% of the 
cells in the splenic preparations,  showed obvious DC mor- 
phology, as shown in Fig. 1. Since this was less than the level 
of class II MHC bright cells, these either included  some 
non-DC or included cells of the dendritic lineage that were 
not able to express DC morphology in short-term culture. 
Dendritic Markers on DC Preparations.  To further check if 
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Figure 1.  The appearance of cells in the 
thymic DC preparations after 15 h of cul- 
ture. The preparations  were not sorted to 
remove  residual  contaminants.  The  cells 
were incubated  in hanging drop cultures, 
but then inverted and allowed to settle on 
the base of Terasaki tray wells. Some cells 
remained round but many adopted  a con- 
voluted shape  with  dendrites,  veils, and 
other cell extensions.  The cultures  were 
photographed under phase contrast (x 100). 3301 
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Figure 2.  The staining of DC preparations with DC-specific mAbs. 
The preparations were not sorted to remove residual contaminants. Biotiny- 
lated mAbs were used with PE-avidin second stage in these single-parameter 
analyses. The dotted line represents the second stage alone background. 
For each fluorescence distribution profile similar results were obtained in 
two to four separate experiments. 
the cells isolated were of the dendritic lineage, the prepara- 
tions were stained with mAbs recognizing antigens reported 
to be specific for DC (Fig. 2). Although some of these gave 
relatively  weak staining,  the results were clear-cut.  Most 
thymic and splenic DC stained positively with 33D1,  a re- 
sult that differs from other reports indicating that thymic 
DC do not stain with this mAb (10, 11). Both thymic and 
splenic DC preparations included cells positive with NLDC 
145, a mAb known to stain the interdigitating type of DC 
(40).  Generally,  two peaks were seen, one negative to low 
and one of higher staining, with thymic DC always showing 
more of the clearly positive staining cells. Finally, both DC 
preparations were strongly positive with MTS 35. The an- 
tigen recognized by this mAb is also found on many lym- 
phoid cells, but among the thymic stromal cell populations, 
it has been found to be selective for thymic DC (41). 
Overall, the results with DC-specific mAbs indicated that 
the majority of cells in our preparations were a form of DC, 
but the spectrum of DC isolated differed from that usually 
obtained. Further evidence that the preparations were pre- 
dominantly DC is the very high level of class II MHC on 
the majority of cells in both preparations (Figs. 3 and 4). 
General Surface Markers on Thymic DC.  The expression 
of a range of surface markers on the thymic DC preparation 
(before  sorting for class II MHC bright cells) is shown in 
Fig. 3. The majority of cells stained very brightly for MHC 
class II (brighter than B cells);  the MHC  class II  ]~  cells 
were considered to represent the non-DC contaminants. The 
thymic DC expressed high levels of MHC class I, CD45 (Ly- 
5), CD44 (Pgp-1), and LFA-1. They also expressed high levels 
of the heat-stable  antigen (HSA; Jlld),  already reported as 
a characteristic of thymic DC (10, 11). All these markers cor- 
related with MHC class II fluorescence, so gating for MHC 
class II bright cells removed most of the negative cells (not 
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Figure 3.  The level of various surface antigens on thymic DC. The cells 
were stained in three fluorescent colors for MHC class II, CD8, and the 
antigen to be studied. The dotted line gives the background, with only 
the biotinylated mAbs under analysis being omitted. (Left) The staining 
profile of a thymocyte  suspension, as a control for staining intensities. 
(Middle) The staining profile of the total thymic DC preparation (not sorted 
to remove residual contaminants).  (Right) The distribution after gating 
the DC preparation for cells expressing high levels of CDS. Gating for 
MHC class II bright cells gave almost identical profiles to CD8 gating. 
Each staining and analysis was performed two to four times with similar 
results. 
shown). The DC were negative for the granulocyte marker 
Gr-1, the macrophage marker F4/80, and the B cell marker 
B220.  However,  they did express low levels of Mac-1 and 
the FcR II. 
General Surface Markers on Splenic DC.  The DC prepara- 
tions isolated from spleen resembled closely those from thymus 
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Figure 4.  The level of various surface antigens on splenic DC. Condi- 
tions were similar to Fig. 3, and the thymocytes of Fig. 3 serve as a control 
for staining  intensities. (Left) The results for the total splenic DC prepara- 
tion (not sorted to remove residual  contaminants). (M/dr/e) The gated results 
for cells expressing high levels of MHC class II. (Right) The gated results 
for cells expressing high levels  of CD8. Note the existence of a small popu- 
lation of HSA- cla~s I[ MHC bright cells, but the absence of HSA- CD8 
bright cells. Each staining and analysis was performed two to four times 
with similar results. 
in expression of the series of markers discussed above (Fig. 
4). There was generally a higher proportion of MHC class 
II-negative contaminants. It was notable that, as for thymic 
DC,  the majority of cells were strongly positive for HSA, 
in contrast to the usual result with splenic DC preparations 
(10,  11). However, there was a  small subgroup  of HSA- 
cells, even after gating for MHC class II bright cells to elimi- 
nate contaminants. Thus, a minor subpopulation of our splenic 
DC resembled the majority population obtained by others. 
T  Cell Markers on  Thyraic DC,  Published studies indi- 
cate that thymic DC express a number of surface antigens 
normally characteristic of T cells (10-12), and our own ear- 
lier studies confirmed the strong expression of CD8 (15). Our 
new isolation procedure was designed to reduce the possi- 
bility that this was simply due to bound thymocytes. We 
verified by phase contrast microscopy that there were no ag- 
gregates or rosettes in the DC preparations, and Giemsa-stained 
cytocentrifuge preparations  showed no signs  of the tight 
binding of thymocytes to some DC we had noted in earlier 
preparations. Nevertheless, our thymic DC still expressed some 
T  cell markers, as shown in Fig.  5.  There was no staining 
with anti-CD3, nor with antibody against the IL-2Rc~ chain, 
confirming the absence ofT cells. However, the DC appeared 
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Figure S.  The distribution on thymic DC of surface antigens usually 
found on T cells. The presentation is similar to Fig. 3. The CD8 fluores- 
cence profiles presented are based on staining with mAb YTS 169.4, with 
the different anti-CD8 53-6.7 mAbs used to gate for CD8 bright cells. 
As in Fig. 3, gating for CD8 bright cells gave very similar results to gating 
for MHC class II bright cells. Each staining and analysis was performed 
two to three  times with similar results. 
to express very low levels of CD4, moderate levels of Thy-1 
and CD2, and a range of levels of CD8, from zero to as bright 
as on T cells. The cells with the highest levels of CD8 showed 
the same pattern of markers seen for the majority DC popu- 
lation, and for the MHC class II bright cells (Figs.  3 and 
5). These CD8 + cells therefore expressed DC markers, and 
in separate experiments were found to show typical DC mor- 
phology after short periods in culture. 
sp , cit  r  'r.sts  for T CelI  Markers o. T mi< DC.  To check 
whether the binding of mAb to DC was specific, especially 
where low level fluorescence was seen, thymic DC were iso- 
lated from different mouse strains, and allotype-specific mAbs 
were used for staining in a crisscross protocol. The staining 
of thymic DC for the Thy-1 antigen was specific, since no 
significant fluorescence above background levels was seen when 
anti-Thy-l.2 mAbs were used to stain Thy-l.1 DC, or when 
anti-Thy-l.1 mAbs were used to stain Thy-l.2 DC (data not 
shown). Likewise, the staining with mAbs recognizing the 
CD8o~ chain (Ly-2) was specific,  since the anti-Ly-2.1 and 
the  anti-Ly-2.2  mAbs  showed  the  appropriate  binding 
specificity, and no significant staining above background was 
seen with the inappropriate allotype (Fig. 6). Positive staining 
for CD8~ was obtained with four different mAbs (Figs.  5 
and 8), indicating the staining was not due to any accidental 
crossreactivity. In each case the CD8ol staining of DC ex- 
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Figure 6.  The specificity and nature of the staining  for CD8 on thymic 
DC. The results are gated for the ,x,90% MHC class II bright calls in 
the thymic DC preparation. The dotted line gives the background fluores- 
cence of samples with only the biotinylated  anti-CD8 mAb omitted. The 
horizontal bars represent the range of fluorescence of the positive peak 
when thymocytes of the same strain are stained with the same antibodies. 
This result  was confirmed in three  other experiments. 
tended to cells as bright as the staining of thymocytes with 
that Ab. Finally, the thymic DC were also stained with mAbs 
recognizing the CD8B chain (Ly-3), indicating the existence 
of some c~/~ CD8 heterodimer resembling that typically  found 
on T cells; however, the level of staining with anti-Ly-3 was 
always well below that of  the thymocyte  controls, suggesting 
the c~/c~ homodimer was the main CD8 form. 
CD8 mRNA in Thymic DC.  To determine whether the 
surface CD8 was synthesized by the DC themselves, rather 
than being picked up from previously associated thymocytes, 
the presence  of  the CD8o~ chain message in purified and sorted 
thymic DC preparations was checked using an RNAse pro- 
tection assay (Fig. 7). Using a CD8ol probe, the sorted, MHC 
class II bright DC exhibited a dear protected band, although 
the level appeared  to be somewhat less than that seen in thymo- 
cytes. Sorting of the CD8 + from the CD8- fractions of the 
MHC class II bright cells showed most of this mRNA was 
in the CD8 + fraction. 
Are Tlrymic DC Deviant T Cells?  The occurrence of  many 
T cell markers on the thymic DC suggested they might have 
developed as a branch off one of the developing thymic T 
ceU lineages. Accordingly, the rearrangement status of the 
TCR/3 and 3' C region genes was assessed, since all but the 
very earliest T precursors in the thymus show rearrangement 
at these loci (47). However, restriction enzyme digestion, 
gel dectrophoresis, and hybridization with CB or C7 probes 
revealed that both these genes were in germline state in most 
thymic DC (Fig. 8). In the case of the C3r probe, a very faint 
band, additional to the three strong gerraline bands, was some- 
times seen around 14 kb. This did not correspond to any of 
the rearranged bands seen with thymocytes, and it was not 
clear whether it represented a rare DC rearrangement, a con- 
taminant cell, or an artifact.  Overall,  these results indicate 
that most DC had not rearranged their TCR genes, and they 
confirm that the preparations  were not contaminated with 
thymocytes or T  precursor  cells. 
T CelIMarkers on Splenic  DC.  In common with the thymic 
DC, those isolated from spleen were negative for CD3 and 
Ib2RoL (Fig. 9).  In contrast with thymic DC,  the splenic 
DC were also negative for CD4, and were either negative 
or very low for Thy-1 and CD2. Thus, most T ceU markers 
Figure 7.  RNAse protection assay  for CD8c~ mRNA in DC. The DC 
preparations from both thymus and spleen were sorted to provide >99% 
MHC class II bright cells. RNA was prepared from 5  x  10  s cells. The 
32p-labded probe was an antisense fragment of Ly-2.2, which protects a 
mRNA fragment to produce a band at 270 bp, the positive signal. Some 
undigested probe persisted as a band at 284 bp. 
Figure 8.  Status of TCR/3 and 3' genes in thymic DC. The DC prepa- 
ration was sorted to provide >99% MHC class II bright cells. DNA was 
prepared from  the purified  thymic  DC  as described in Materials  and 
Methods. For TCK/~ gene rearrangement, DNA was digested with HindlII 
and hybridized with a C/3 probe. Kidney DNA served as a germline con- 
trol, showing two germline bands of 9.4 kb (C~1) and 3.0 kb (CB2). 
As only the 9.4-kb band changed on rearrangement,  the ratio of intensity 
of these two bands served as rough measure of the extent of rearrange- 
ment. For TCK 3' gene rearrangement,  DNA was digested with EcoRI 
and hybridized with a C'y probe. Kidney DNA served as a germline con- 
trol, showing three germline bands at 13.4, 10.5, and 7.5 kb. C7 rear- 
rangement was detected by the appearance of discrete additional bands, 
as shown in the thymus control sample. 
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Figure 9.  The distribution on splenic DC of surface antigens  usually 
found on T cells. The presentation is similar to that of Figs. 4 and 5. (Left) 
The staining  of a spleen lymphoid cell suspension,  the 30%  T  calls in 
the suspension serving as a staining control. (Middle) The results for the 
total depleted splenic DC preparation  (not sorted to remove residual con- 
taminants). (Right) The same data gated for the 80% MHC class II bright 
cells. Similar results were obtained  three  times for CD8, and twice for 
the other markers. 
were absent from these cells. However, an unexpectedly high 
proportion  expressed high levels of CD8. 
The expression of CD8 on the splenic DC was examined 
in more detail (Fig.  9). Rather than  a continuum,  as with 
thymic DC,  the population  fell into  two groups,  a major 
CD8 bright  and a minor CD8-  group.  Gating  for MHC 
class  II bright  cells  usually eliminated  some of the CD8- 
cells,  but  confirmed  that  the  division  into  a  majority  of 
CD8 + and  a minority  of CD8-  cells  applied  to  the den- 
dritic component of the preparation.  Despite the expression 
of CD8oe (Ly-2), the splenic DC expressed no, or at most 
very low,  levels  of CD8B  (Ly-3).  The  clear peak  of both 
CD8oe + and CD8/3 + mature T cells seen among total spleen 
cells in side-by-side staining tubes confirmed this absence of 
CD8B from the splenic DC  (Fig.  9). 
CD8 mRNA  in Splenic DC.  The issue of whether the 
CD8oe was synthesized by the splenic DC was examined by 
assaying for mRNA using an RNAse protection assay. A clear 
band of CD8oe mRNA was also observed in the MHC class 
II bright sorted splenic DC (Fig. 7), the level being even higher 
than  seen  with  thymocytes. 
Differences between Free and Tissue Bound Splenic DC.  The 
population of splenic DC we isolated was dominated by a 
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Figure 10.  A comparison of the CD8 expression  by loosely  and tightly 
tissue-bound splenic DC. The flee, or loosdy bound, DC were released 
from tissue by teasing the spleens apart, followed  by vigorous mechanical 
agitation. The bound DC were then released from the washed stromal 
residue by collagenase digestion. The preparations were stained for both 
CD8 and class II MHC, and the results presented are gated for the class 
II MHC bright DC. The dotted line gives the background for cells stained 
for MHC class II, but with anti-CD8 omitted. The numbers of DC re- 
covered per spleen are given for this experiment. The results are typical 
of four such experiments. 
CD8 +  HSA §  population,  with  CD8-  HSA-  cells  as  a 
minor subgroup. Since this was the converse of the distribu- 
tion reported by others (11), we checked which aspect of the 
various separation procedures produced the bias. DC first iso- 
lated by our procedure from partially washed splenic stromal 
fragments were separated into cdls showing transient adher- 
ence to plastic surfaces  (59%) and those completely nonad- 
herent  (41%).  The  transiently  adherent  cells  were  43% 
CD8 + , and the nonadherent  cells were 57% CD8 § . Thus, 
there was some enrichment of CD8-  DC by the adherence 
procedure,  but  not  enough  to  explain  the  dominance  of 
CD8- DC reported by others. Little difference was seen be- 
tween the two DC types when a higher density medium was 
used in the centrifugation step in order to recover more DC. 
In contrast,  marked differences were seen between the DC 
released from spleen by mechanical disruption and those re- 
quiring additional enzyme digestion and EDTA treatment. 
A comparison of the DC recovered from our normally dis- 
carded disrupted spleen washings (~30%  of all recoverable 
DC) with those recovered by our usual digestion procedure 
is given in Fig. 10. The mechanically released DC were pre- 
dominantly,  but not  exclusively,  CD8-,  whereas  the col- 
lagenase released DC were, as before, predominantly CD8 +. 
Our original procedure therefore gave a sample of DC strongly 
biased by selection for tissue-bound cells. 
Discussion 
Subpopulations of Spleni~ DC and Their Recovery after Different 
Isolation Procedures.  One practical conclusion from this study 
is that  the separation procedure used can strongly bias the 
subpopulation distribution of isolated DC. Although the DC 
yield was high,  our original procedure, involving mechan- 
ical disruption  of the tissue and washing out all free lym- 
phoid cells before collagenase digestion and EDTA treatment, 
had caused the selective loss of '~30% of splenic DC. Con- 
versely, procedures that do not use collagenase and then EDTA 
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biased towards those with a loose tissue association. Espe- 
dally with thymic tissue, the failure  to disrupt DC-lymphocyte 
rosettes with the chelating agent would cause significant loss 
of DC, since the rosettes would be lost in the dense fraction 
during selection for low-density DC. In spleen, the tightly 
tissue-bound  DC  are predominantly CD8 +,  whereas  the 
loosely bound DC include more CDS-  than CD8 + cells. 
The  strongly bound  splenic  DC  are  also HSAhig  h  and 
NLDC145hag  h, which fits with the conclusions of others that 
this phenotype corresponds to the interdigitating DC (11, 
40). The loosely bound splenic DC presumably include the 
HSA  l~  NLDC145 l~  DC population that has been consid- 
ered as a motile, migratory stage (10). 
Another likely source of bias is the preferential attachment 
of certain DC populations  to plastic surfaces during the ad- 
herence step of the usual isolation procedure. We observed 
some selection for CDS- DC by this procedure and have re- 
cently noted a strong selection for 33D1 + DC. In addition, 
if rosettes are not disrupted before this step, rosette-associated 
DC will be lost, since dendritic rosettes are nonadherent (14, 
16). It is also possible that the incubation at 37~  itself may 
result in changes in the surface phenotype, since changes in 
DC viability and function due to a period of culture have 
been reported (7, 48). Our rapid, direct isolation procedure 
was designed to avoid this adherence step. Similar considera- 
tions led Crowley et al. (48) to develop a procedure for direct 
sorting of DC from the low-buoyant density spleen fraction 
using the mAb N418. 
Our focus in this study has been on the class of DC known 
to present antigen to T cells. It should be noted that the sep- 
arate lineage of follicular dendritic cells (FDC) (49), which 
present  antigen to B cells, are not evident in our prepara- 
tions. They have been deliberately selected out by the inclu- 
sion of mAb specific for the FcR during the depletion step. 
Our final separation procedure is rapid and produces a high 
yield of DC. The bias in subpopulation  distribution can be 
avoided if the readily released, as well as the tissue-bound, 
DC are collected. For many applications, the use of mag- 
netic bead depletion avoids the need for cell sorting.  How- 
ever, since selection by magnetic bead depletion is by nega- 
tive criteria, certain infrequent cell types may be concentrated 
in the preparation along with the DC, and some undepleted 
contaminants remain. Positive sorting for cells bearing high 
levels of MHC class II, or on the basis of other markers, is 
essential for high purity. Because  DC are already the majority 
population, sorting time is greatly reduced compared with 
direct sorting from an undepleted suspension. 
Tkymic DC and T  Cells Markers.  The DC we isolated 
from the thymus shared many properties with the tissue-bound 
interdigitating population we isolated from the spleen, in being 
HSA  rash, NLDC145 + MTS35  + CD45 +  , CD44 + FcR IP  ~ 
Mac-1  l~  F4/80-, Gr-1-, and B220-. These markers agree 
well with those reported by others using different isolation 
procedures (10-12). However, most of the thymic DC we 
isolated stained positively with mAb 33D1, in contrast with 
most reports,  although some nonadherent 33D1 + thymic 
DC have been noted previously (11). This difference could 
result from the selective effects of different isolation proce- 
dures as discussed above, but it could also reflect an increased 
sensitivity in detection of a relatively weak-staining  mAb. 
The major differences  we found between thymic and splenic 
DC, even when paired for the same "interdigitating DC" 
markers, were in the expression of a series of characteristic 
T cell surface markers. The central issue of CD8 expression 
is discussed in detail below. Thymic DC also had on their 
surface moderate levels of Thy-1 and CD2,  and low levels 
of CD4; these were absent or at much lower levels on the 
corresponding splenic DC. This was not due to T  cell or 
thymocyte contamination, as evident from the lack of CD3 
staining, the lack of Ib2Ko~ staining, the lack of character- 
istic T cell or thymocyte TCK gene rearrangements in the 
DNA, the distribution of other markers, and the absence of 
associated thymocytes  in stained preparations. For Thy-1 and 
CD8, the aUotype  controls indicated the staining was specific, 
and the absence of staining on splenic DC prepared by the 
same procedure reinforces this point. These T cell markers 
(except for CD8) have not been detected previously by others, 
nor detected by us using the standard isolation procedures (15). 
We have two alternative explanations for the low expres- 
sion of these T cell markers on our thymic DC, but not on 
our splenic DC. Due to their residence or development  in 
the thymus, thymic DC may  be subject to the same inducing 
factors as developing T cells, and so synthesis of a low level 
of these surface components may be induced either as an ac- 
cidental bystander effect, or as a necessary requirement for 
function or persistence within the organ. The second, alter- 
native explanation is that these surface components are not 
synthesized by the DC, but are picked up from the mem- 
branes of associated  thymocytes.  The difference  between thymic 
and splenic DC would then be due to the tight association 
of thymic DC with thymocytes in rosettes. The failure to 
detect these markers following the standard DC cell isola- 
tion procedures would then be due to the exclusion of rosette- 
associated DC from the preparation,  or due to the washing 
off of the bound material during the incubation procedure. 
This explanation can be excluded for CDSot chains, but it 
is a reasonable one for the other T  cell markers present at 
lower levels on the DC surface. 
CD8 Expression by DC.  The most intriguing of the T 
cell markers expressed by DC is CD8.  Nussenzweig et al. 
(50) and Crowley et al. (10, 48) had already reported the ex- 
pression of CD8 by many thymic DC and by what was con- 
sidered a minor population of splenic DC. We had already 
noted the presence of this marker on thymic DC using stan- 
dard isolation procedures (15). With our new"  isolation pro- 
cedure selective for the strongly tissue-associated splenic DC, 
the CD8 + DC were the dominant population.  We estimate 
that in the spleen as a whole about half the DC express CD8, 
a proportion at least as high as in thymus. In addition,  the 
level of CD8 expressed is about as high as on CD8 + T cells 
and thymocytes. This forced us to check the reality of this 
CD8 expression and consider its biological significance. 
It appears the surface molecule stained is authentic CD8, 
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tribution  in different mouse strains  shows the appropriate 
allotype specificity.  The high surface level, and the fact that 
the form of CD8 on DC differs from that on the surrounding 
T  cells,  makes it unlikely that it is merely picked up from 
T  cells. The presence of CD8c~ mRNA in both splenic and 
thymic DC confirms that the c~ chain is synthesized by the 
DC  themselves. 
An intriguing and novel observation is that while thymic 
DC do express some CD8 3  chain,  the cr chain appears to 
be in excess,  and the ot chain is the predominant  form on 
splenic DC.  Thus,  rather  than  the ot/3 heterodimer  form 
of CD8 characteristic of most TCR or/3 T cells, the domi- 
nant form of CD8 characteristic of most TCR or/3 T cells, 
the dominant form of CD8 on DC is the or/or homodimer. 
The CD8 c~/c~ homodimer is the form commonly seen on 
TCR qr/6 T  cells and on the few or/3 T  cells that develop 
extrathymicaUy (51).  To date there is no evidence that  the 
homodimer and heterodimer forms of CD8 differ in function. 
Significance of C08 Expression by DC.  The high level of 
CD8 expression by DC, unique outside the T lineage, sug- 
gests a functional role. Hambor et al. (52) have pointed out 
that as well as its accepted role in T lymphocyte stimulation 
as a binding receptor for MHC class I, CD8 can serve as an 
inhibitory ligand depressing immune responses. Such a role 
has been delineated by Sambhara and Miller (53), who have 
found that CD8 is required for a cell to exhibit veto func- 
tion. T cells recognizing antigen presented by the MHC of 
a veto cell are signaled to die if, as well as receiving a signal 
through their TCR, they receive a signal through their MHC 
class I as a result of its interaction with the CD8 of the veto 
cell.  Cells transfected with CD8ot chain alone appear to ac- 
quire veto function (52, 53).  In most systems the veto cell 
has been a CDS-bearing T  cell.  However, the efficiency of 
DC in antigenic peptide presentation  via class I or class II 
MHC should, if the DC expresses high levels of CDS, lead 
to an equally efficient veto function. 
This reasoning would provide a good explanation of the 
role of CD8 on thymic DC. As well as an ability to initiate 
the death of immature thymocytes by a simple TCR-mediated 
signal,  deletion could be extended to more mature thymo- 
cytes in the medulla by adding a CD8 interaction signal trans- 
mitted through class I.  However, in this light,  the finding 
of a large population of CD8 + DC in the spleen comes as 
a surprise.  If the splenic CD8 + DC do function as veto cells, 
the implication of having two distinct DC subgroups in the 
spleen, one very effective at presenting antigen and stimulating 
T cells, the other at presenting antigen and deleting T cells, 
must be considered. We are currently studying the separate 
immunological  activities of these subpopulations  of DC. 
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